HEADER OXIDOREDUCTASE 06-APR-21 7O4D TITLE QR2 INHIBITOR FROM A NOVEL SULFANAMIDE SERIES TO TACKLE AGE RELATED TITLE 2 OXIDATIVE STRESS AND COGNITIVE DECLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NRH DEHYDROGENASE [QUINONE] 2,NRH:QUINONE OXIDOREDUCTASE 2, COMPND 5 QUINONE REDUCTASE 2,QR2; COMPND 6 EC: 1.10.5.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NQO2, NMOR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITORS, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR N.L.GOULD,G.R.SCHERER,S.CARVALH,K.SHURRUSH,E.EDRY,A.ELKOBI,O.DAVID, AUTHOR 2 O.DYM,S.ALBECK,Y.PELEG,N.GERMAIN,I.BABAEV,H.SHARIR,B.LEFKER, AUTHOR 3 C.SUBRAMANYAM,H.BARR,K.ROSENBLUM REVDAT 3 28-FEB-24 7O4D 1 JRNL REVDAT 2 31-JAN-24 7O4D 1 REMARK REVDAT 1 17-AUG-22 7O4D 0 JRNL AUTH N.L.GOULD,G.R.SCHERER,S.CARVALHO,K.SHURRUSH,H.KAYYAL,E.EDRY, JRNL AUTH 2 A.ELKOBI,O.DAVID,M.FOQARA,D.THAKAR,T.PAVESI,V.SHARMA, JRNL AUTH 3 M.WALKER,M.MAITLAND,O.DYM,S.ALBECK,Y.PELEG,N.GERMAIN, JRNL AUTH 4 I.BABAEV,H.SHARIR,M.LALZAR,B.SHKLYAR,N.HAZUT,M.KHAMAISY, JRNL AUTH 5 M.LEVESQUE,G.LAJOIE,M.AVOLI,G.AMITAI,B.LEFKER,C.SUBRAMANYAM, JRNL AUTH 6 B.SHILTON,H.BARR,K.ROSENBLUM JRNL TITL SPECIFIC QUINONE REDUCTASE 2 INHIBITORS REDUCE METABOLIC JRNL TITL 2 BURDEN AND REVERSE ALZHEIMER'S DISEASE PHENOTYPE IN MICE. JRNL REF J.CLIN.INVEST. V. 133 2023 JRNL REFN ISSN 0021-9738 JRNL PMID 37561584 JRNL DOI 10.1172/JCI162120 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1231 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.0700 - 4.6757 1.00 2769 158 0.1445 0.1696 REMARK 3 2 4.6757 - 3.7117 1.00 2666 141 0.1328 0.1678 REMARK 3 3 3.7117 - 3.2427 1.00 2630 129 0.1743 0.2100 REMARK 3 4 3.2427 - 2.9462 1.00 2582 137 0.2009 0.2875 REMARK 3 5 2.9462 - 2.7351 1.00 2618 127 0.2095 0.2821 REMARK 3 6 2.7351 - 2.5739 1.00 2592 133 0.2052 0.2926 REMARK 3 7 2.5739 - 2.4450 1.00 2586 133 0.2012 0.2730 REMARK 3 8 2.4450 - 2.3385 1.00 2584 134 0.1867 0.2752 REMARK 3 9 2.3385 - 2.2490 0.99 2522 139 0.1824 0.2306 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.720 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7O4D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-21. REMARK 100 THE DEPOSITION ID IS D_1292115094. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5419 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24796 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.249 REMARK 200 RESOLUTION RANGE LOW (A) : 47.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.20 REMARK 200 R MERGE (I) : 0.20000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 10.20 REMARK 200 R MERGE FOR SHELL (I) : 0.69410 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5LBU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.7 M AMMONIUM TARTRATE DIABASIC AND REMARK 280 50 MM TRIS PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.51550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.24300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.68100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.24300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.51550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.68100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -16 REMARK 465 ALA A -15 REMARK 465 GLY A -14 REMARK 465 LEU A -13 REMARK 465 ASN A -12 REMARK 465 ASP A -11 REMARK 465 ILE A -10 REMARK 465 PHE A -9 REMARK 465 GLU A -8 REMARK 465 ALA A -7 REMARK 465 GLN A -6 REMARK 465 LYS A -5 REMARK 465 ILE A -4 REMARK 465 GLU A -3 REMARK 465 TRP A -2 REMARK 465 HIS A -1 REMARK 465 GLU A 0 REMARK 465 MET A 1 REMARK 465 GLN A 231 REMARK 465 MET B -16 REMARK 465 ALA B -15 REMARK 465 GLY B -14 REMARK 465 LEU B -13 REMARK 465 ASN B -12 REMARK 465 ASP B -11 REMARK 465 ILE B -10 REMARK 465 PHE B -9 REMARK 465 GLU B -8 REMARK 465 ALA B -7 REMARK 465 GLN B -6 REMARK 465 LYS B -5 REMARK 465 ILE B -4 REMARK 465 GLU B -3 REMARK 465 TRP B -2 REMARK 465 HIS B -1 REMARK 465 GLU B 0 REMARK 465 MET B 1 REMARK 465 GLN B 231 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 16 NZ REMARK 470 GLU A 64 CD OE1 OE2 REMARK 470 LYS A 77 CD CE NZ REMARK 470 LYS A 90 CD CE NZ REMARK 470 LYS A 158 CG CD CE NZ REMARK 470 GLU A 199 CG CD OE1 OE2 REMARK 470 LYS A 202 CE NZ REMARK 470 GLN A 210 CG CD OE1 NE2 REMARK 470 HIS A 226 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 64 CG CD OE1 OE2 REMARK 470 GLU B 154 CG CD OE1 OE2 REMARK 470 GLU B 194 CG CD OE1 OE2 REMARK 470 GLU B 199 CG CD OE1 OE2 REMARK 470 LYS B 202 CG CD CE NZ REMARK 470 LYS B 217 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 133 -129.68 54.10 REMARK 500 TYR A 156 50.98 -92.19 REMARK 500 THR A 176 -68.08 -109.37 REMARK 500 ASN B 62 93.30 -163.43 REMARK 500 TYR B 133 -115.20 49.02 REMARK 500 TYR B 156 56.02 -98.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 174 ND1 REMARK 620 2 HIS A 178 ND1 105.8 REMARK 620 3 CYS A 223 O 106.5 101.1 REMARK 620 4 CYS A 223 SG 128.6 114.4 96.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 174 ND1 REMARK 620 2 HIS B 178 ND1 103.6 REMARK 620 3 CYS B 223 O 110.0 100.0 REMARK 620 4 CYS B 223 SG 129.8 113.8 95.5 REMARK 620 N 1 2 3 DBREF 7O4D A 1 231 UNP P16083 NQO2_HUMAN 1 231 DBREF 7O4D B 1 231 UNP P16083 NQO2_HUMAN 1 231 SEQADV 7O4D MET A -16 UNP P16083 INITIATING METHIONINE SEQADV 7O4D ALA A -15 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLY A -14 UNP P16083 EXPRESSION TAG SEQADV 7O4D LEU A -13 UNP P16083 EXPRESSION TAG SEQADV 7O4D ASN A -12 UNP P16083 EXPRESSION TAG SEQADV 7O4D ASP A -11 UNP P16083 EXPRESSION TAG SEQADV 7O4D ILE A -10 UNP P16083 EXPRESSION TAG SEQADV 7O4D PHE A -9 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLU A -8 UNP P16083 EXPRESSION TAG SEQADV 7O4D ALA A -7 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLN A -6 UNP P16083 EXPRESSION TAG SEQADV 7O4D LYS A -5 UNP P16083 EXPRESSION TAG SEQADV 7O4D ILE A -4 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLU A -3 UNP P16083 EXPRESSION TAG SEQADV 7O4D TRP A -2 UNP P16083 EXPRESSION TAG SEQADV 7O4D HIS A -1 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLU A 0 UNP P16083 EXPRESSION TAG SEQADV 7O4D PHE A 47 UNP P16083 LEU 47 ENGINEERED MUTATION SEQADV 7O4D MET B -16 UNP P16083 INITIATING METHIONINE SEQADV 7O4D ALA B -15 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLY B -14 UNP P16083 EXPRESSION TAG SEQADV 7O4D LEU B -13 UNP P16083 EXPRESSION TAG SEQADV 7O4D ASN B -12 UNP P16083 EXPRESSION TAG SEQADV 7O4D ASP B -11 UNP P16083 EXPRESSION TAG SEQADV 7O4D ILE B -10 UNP P16083 EXPRESSION TAG SEQADV 7O4D PHE B -9 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLU B -8 UNP P16083 EXPRESSION TAG SEQADV 7O4D ALA B -7 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLN B -6 UNP P16083 EXPRESSION TAG SEQADV 7O4D LYS B -5 UNP P16083 EXPRESSION TAG SEQADV 7O4D ILE B -4 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLU B -3 UNP P16083 EXPRESSION TAG SEQADV 7O4D TRP B -2 UNP P16083 EXPRESSION TAG SEQADV 7O4D HIS B -1 UNP P16083 EXPRESSION TAG SEQADV 7O4D GLU B 0 UNP P16083 EXPRESSION TAG SEQADV 7O4D PHE B 47 UNP P16083 LEU 47 ENGINEERED MUTATION SEQRES 1 A 248 MET ALA GLY LEU ASN ASP ILE PHE GLU ALA GLN LYS ILE SEQRES 2 A 248 GLU TRP HIS GLU MET ALA GLY LYS LYS VAL LEU ILE VAL SEQRES 3 A 248 TYR ALA HIS GLN GLU PRO LYS SER PHE ASN GLY SER LEU SEQRES 4 A 248 LYS ASN VAL ALA VAL ASP GLU LEU SER ARG GLN GLY CYS SEQRES 5 A 248 THR VAL THR VAL SER ASP LEU TYR ALA MET ASN PHE GLU SEQRES 6 A 248 PRO ARG ALA THR ASP LYS ASP ILE THR GLY THR LEU SER SEQRES 7 A 248 ASN PRO GLU VAL PHE ASN TYR GLY VAL GLU THR HIS GLU SEQRES 8 A 248 ALA TYR LYS GLN ARG SER LEU ALA SER ASP ILE THR ASP SEQRES 9 A 248 GLU GLN LYS LYS VAL ARG GLU ALA ASP LEU VAL ILE PHE SEQRES 10 A 248 GLN PHE PRO LEU TYR TRP PHE SER VAL PRO ALA ILE LEU SEQRES 11 A 248 LYS GLY TRP MET ASP ARG VAL LEU CYS GLN GLY PHE ALA SEQRES 12 A 248 PHE ASP ILE PRO GLY PHE TYR ASP SER GLY LEU LEU GLN SEQRES 13 A 248 GLY LYS LEU ALA LEU LEU SER VAL THR THR GLY GLY THR SEQRES 14 A 248 ALA GLU MET TYR THR LYS THR GLY VAL ASN GLY ASP SER SEQRES 15 A 248 ARG TYR PHE LEU TRP PRO LEU GLN HIS GLY THR LEU HIS SEQRES 16 A 248 PHE CYS GLY PHE LYS VAL LEU ALA PRO GLN ILE SER PHE SEQRES 17 A 248 ALA PRO GLU ILE ALA SER GLU GLU GLU ARG LYS GLY MET SEQRES 18 A 248 VAL ALA ALA TRP SER GLN ARG LEU GLN THR ILE TRP LYS SEQRES 19 A 248 GLU GLU PRO ILE PRO CYS THR ALA HIS TRP HIS PHE GLY SEQRES 20 A 248 GLN SEQRES 1 B 248 MET ALA GLY LEU ASN ASP ILE PHE GLU ALA GLN LYS ILE SEQRES 2 B 248 GLU TRP HIS GLU MET ALA GLY LYS LYS VAL LEU ILE VAL SEQRES 3 B 248 TYR ALA HIS GLN GLU PRO LYS SER PHE ASN GLY SER LEU SEQRES 4 B 248 LYS ASN VAL ALA VAL ASP GLU LEU SER ARG GLN GLY CYS SEQRES 5 B 248 THR VAL THR VAL SER ASP LEU TYR ALA MET ASN PHE GLU SEQRES 6 B 248 PRO ARG ALA THR ASP LYS ASP ILE THR GLY THR LEU SER SEQRES 7 B 248 ASN PRO GLU VAL PHE ASN TYR GLY VAL GLU THR HIS GLU SEQRES 8 B 248 ALA TYR LYS GLN ARG SER LEU ALA SER ASP ILE THR ASP SEQRES 9 B 248 GLU GLN LYS LYS VAL ARG GLU ALA ASP LEU VAL ILE PHE SEQRES 10 B 248 GLN PHE PRO LEU TYR TRP PHE SER VAL PRO ALA ILE LEU SEQRES 11 B 248 LYS GLY TRP MET ASP ARG VAL LEU CYS GLN GLY PHE ALA SEQRES 12 B 248 PHE ASP ILE PRO GLY PHE TYR ASP SER GLY LEU LEU GLN SEQRES 13 B 248 GLY LYS LEU ALA LEU LEU SER VAL THR THR GLY GLY THR SEQRES 14 B 248 ALA GLU MET TYR THR LYS THR GLY VAL ASN GLY ASP SER SEQRES 15 B 248 ARG TYR PHE LEU TRP PRO LEU GLN HIS GLY THR LEU HIS SEQRES 16 B 248 PHE CYS GLY PHE LYS VAL LEU ALA PRO GLN ILE SER PHE SEQRES 17 B 248 ALA PRO GLU ILE ALA SER GLU GLU GLU ARG LYS GLY MET SEQRES 18 B 248 VAL ALA ALA TRP SER GLN ARG LEU GLN THR ILE TRP LYS SEQRES 19 B 248 GLU GLU PRO ILE PRO CYS THR ALA HIS TRP HIS PHE GLY SEQRES 20 B 248 GLN HET ZN A 301 1 HET FAD A 302 53 HET SO4 A 303 5 HET V1Z B 301 26 HET ZN B 302 1 HET FAD B 303 53 HET V1Z B 304 26 HETNAM ZN ZINC ION HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM SO4 SULFATE ION HETNAM V1Z 8-METHYL-2-(4-METHYL-3-PIPERAZIN-1-YLSULFONYL-PHENYL) HETNAM 2 V1Z IMIDAZO[1,2-A]PYRIDINE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 FAD 2(C27 H33 N9 O15 P2) FORMUL 5 SO4 O4 S 2- FORMUL 6 V1Z 2(C19 H22 N4 O2 S) FORMUL 10 HOH *116(H2 O) HELIX 1 AA1 SER A 17 GLN A 33 1 17 HELIX 2 AA2 THR A 52 ILE A 56 5 5 HELIX 3 AA3 ASN A 67 GLN A 78 1 12 HELIX 4 AA4 ALA A 82 ALA A 95 1 14 HELIX 5 AA5 PRO A 110 LEU A 121 1 12 HELIX 6 AA6 PHE A 132 GLY A 136 5 5 HELIX 7 AA7 ASP A 164 HIS A 174 1 11 HELIX 8 AA8 LEU A 177 GLY A 181 5 5 HELIX 9 AA9 SER A 197 THR A 214 1 18 HELIX 10 AB1 ILE A 215 GLU A 218 5 4 HELIX 11 AB2 THR A 224 GLY A 230 1 7 HELIX 12 AB3 SER B 17 GLN B 33 1 17 HELIX 13 AB4 THR B 52 ILE B 56 5 5 HELIX 14 AB5 ASN B 67 ARG B 79 1 13 HELIX 15 AB6 ALA B 82 ALA B 95 1 14 HELIX 16 AB7 PRO B 110 LEU B 121 1 12 HELIX 17 AB8 PHE B 132 GLY B 136 5 5 HELIX 18 AB9 ALA B 153 THR B 157 5 5 HELIX 19 AC1 ASP B 164 HIS B 174 1 11 HELIX 20 AC2 SER B 197 THR B 214 1 18 HELIX 21 AC3 ILE B 215 GLU B 218 5 4 HELIX 22 AC4 THR B 224 GLY B 230 1 7 SHEET 1 AA1 5 THR A 36 ASP A 41 0 SHEET 2 AA1 5 LYS A 5 TYR A 10 1 N VAL A 6 O THR A 36 SHEET 3 AA1 5 LEU A 97 PRO A 103 1 O ILE A 99 N VAL A 9 SHEET 4 AA1 5 LEU A 142 THR A 148 1 O SER A 146 N PHE A 100 SHEET 5 AA1 5 LYS A 183 VAL A 184 1 O LYS A 183 N ALA A 143 SHEET 1 AA2 5 THR A 36 ASP A 41 0 SHEET 2 AA2 5 LYS A 5 TYR A 10 1 N VAL A 6 O THR A 36 SHEET 3 AA2 5 LEU A 97 PRO A 103 1 O ILE A 99 N VAL A 9 SHEET 4 AA2 5 LEU A 142 THR A 148 1 O SER A 146 N PHE A 100 SHEET 5 AA2 5 GLN A 188 SER A 190 1 O GLN A 188 N LEU A 145 SHEET 1 AA3 5 THR B 36 ASP B 41 0 SHEET 2 AA3 5 LYS B 5 TYR B 10 1 N ILE B 8 O THR B 38 SHEET 3 AA3 5 LEU B 97 PRO B 103 1 O ILE B 99 N VAL B 9 SHEET 4 AA3 5 LEU B 142 THR B 149 1 O SER B 146 N PHE B 100 SHEET 5 AA3 5 LYS B 183 VAL B 184 1 O LYS B 183 N ALA B 143 SHEET 1 AA4 5 THR B 36 ASP B 41 0 SHEET 2 AA4 5 LYS B 5 TYR B 10 1 N ILE B 8 O THR B 38 SHEET 3 AA4 5 LEU B 97 PRO B 103 1 O ILE B 99 N VAL B 9 SHEET 4 AA4 5 LEU B 142 THR B 149 1 O SER B 146 N PHE B 100 SHEET 5 AA4 5 GLN B 188 PHE B 191 1 O GLN B 188 N LEU B 145 LINK ND1 HIS A 174 ZN ZN A 301 1555 1555 2.13 LINK ND1 HIS A 178 ZN ZN A 301 1555 1555 2.10 LINK O CYS A 223 ZN ZN A 301 1555 1555 2.22 LINK SG CYS A 223 ZN ZN A 301 1555 1555 2.30 LINK ND1 HIS B 174 ZN ZN B 302 1555 1555 2.02 LINK ND1 HIS B 178 ZN ZN B 302 1555 1555 2.13 LINK O CYS B 223 ZN ZN B 302 1555 1555 2.15 LINK SG CYS B 223 ZN ZN B 302 1555 1555 2.41 CISPEP 1 ILE A 129 PRO A 130 0 10.92 CISPEP 2 ILE B 129 PRO B 130 0 -1.21 CRYST1 57.031 83.362 106.486 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017534 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011996 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009391 0.00000